We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · January 02, 2021

Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials
J. Clin. Oncol 2020 Dec 23;[EPub Ahead of Print], R Cohen, J Taieb, J Fiskum, G Yothers, R Goldberg, T Yoshino, S Alberts, C Allegra, A de Gramont, J-F Seitz, M O'Connell, D Haller, N Wolmark, C Erlichman, A Zaniboni, S Lonardi, R Kerr, A Grothey, FA Sinicrope, T André, Q Shi

Further Reading